Literature DB >> 22521523

Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.

Jessica Jones-Carson1, James R Laughlin, Amanda L Stewart, Martin I Voskuil, Andrés Vázquez-Torres.   

Abstract

Burkholderia pseudomallei infections are fastidious to treat with conventional antibiotic therapy, often involving a combination of drugs and long-term regimes. Bacterial genetic determinants contribute to the resistance of B. pseudomallei to many classes of antibiotics. In addition, anaerobiosis and hypoxia in abscesses typical of melioidosis select for persistent populations of B. pseudomallei refractory to a broad spectrum of antibacterials. We tested the susceptibility of B. pseudomallei to the drugs hydroxyurea, spermine NONOate and DETA NONOate that release nitric oxide (NO). Our investigations indicate that B. pseudomallei are killed by NO in a concentration and time-dependent fashion. The cytoxicity of this diatomic radical against B. pseudomallei depends on both the culture medium and growth phase of the bacteria. Rapidly growing, but not stationary phase, B. pseudomallei are readily killed upon exposure to the NO donor spermine NONOate. NO also has excellent antimicrobial activity against anaerobic B. pseudomallei. In addition, persistent bacteria highly resistant to most conventional antibiotics are remarkably susceptible to NO. Sublethal concentrations of NO inhibited the enzymatic activity of [4Fe-4S]-cofactored aconitase of aerobic and anaerobic B. pseudomallei. The strong anti-B. pseudomallei activity of NO described herein merits further studies on the application of NO-based antibiotics for the treatment of melioidosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521523      PMCID: PMC3517295          DOI: 10.1016/j.niox.2012.04.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  52 in total

1.  Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes.

Authors:  Samart Pakakasama; Gretchen M Eames; Michael C Morriss; M Helen Huls; Cliona M Rooney; Helen E Heslop; Robert A Krance
Journal:  Transplantation       Date:  2004-09-15       Impact factor: 4.939

2.  beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.

Authors:  D M Livermore; P Y Chau; A I Wong; Y K Leung
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

3.  Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not.

Authors:  A Hausladen; I Fridovich
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

4.  Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide.

Authors:  L Castro; M Rodriguez; R Radi
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

5.  Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-gamma-induced nitric oxide production by rat alveolar macrophages.

Authors:  P G Jorens; F J van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Agents Actions       Date:  1993-01

6.  Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole.

Authors:  M Vorachit; K Lam; P Jayanetra; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

7.  Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model.

Authors:  M A De Groote; D Granger; Y Xu; G Campbell; R Prince; F C Fang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei.

Authors:  Y Y Chan; T M C Tan; Y M Ong; K L Chua
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

9.  Nitric oxide production does not directly increase macrophage candidacidal activity.

Authors:  A Vazquez-Torres; J Jones-Carson; E Balish
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.

Authors:  N S Kwon; D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Reactive nitrogen species in host-bacterial interactions.

Authors:  Ferric C Fang; Andrés Vázquez-Torres
Journal:  Curr Opin Immunol       Date:  2019-06-12       Impact factor: 7.486

2.  Deciphering nitric oxide stress in bacteria with quantitative modeling.

Authors:  Jonathan L Robinson; Kristin J Adolfsen; Mark P Brynildsen
Journal:  Curr Opin Microbiol       Date:  2014-06-29       Impact factor: 7.934

3.  Relative susceptibility of airway organisms to antimicrobial effects of nitric oxide.

Authors:  Alan D Workman; Ryan M Carey; Michael A Kohanski; David W Kennedy; James N Palmer; Nithin D Adappa; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2017-05-25       Impact factor: 3.858

4.  Nitric Oxide Inhibition of Rickettsia rickettsii.

Authors:  Liam F Fitzsimmons; Tina R Clark; Ted Hackstadt
Journal:  Infect Immun       Date:  2021-09-07       Impact factor: 3.441

5.  Fe(II) oxidation is an innate capability of nitrate-reducing bacteria that involves abiotic and biotic reactions.

Authors:  Hans K Carlson; Iain C Clark; Steven J Blazewicz; Anthony T Iavarone; John D Coates
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

6.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

7.  Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of β-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella.

Authors:  Jessica Jones-Carson; Adrienne E Zweifel; Timothy Tapscott; Chad Austin; Joseph M Brown; Kenneth L Jones; Martin I Voskuil; Andrés Vázquez-Torres
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

8.  Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophages.

Authors:  Minal Mulye; Michael P Bechill; William Grose; Viviana P Ferreira; Eric R Lafontaine; R Mark Wooten
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

9.  Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei.

Authors:  Saja Asakrah; Wildaliz Nieves; Zaid Mahdi; Mallory Agard; Arnold H Zea; Chad J Roy; Lisa A Morici
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09

10.  Antibacterial responses of retinal Müller glia: production of antimicrobial peptides, oxidative burst and phagocytosis.

Authors:  Pawan Kumar Singh; Melissa J Shiha; Ashok Kumar
Journal:  J Neuroinflammation       Date:  2014-02-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.